Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma
International Journal of Clinical Oncology · 2023
DOI: 10.1007/s10147-023-02416-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2023. Verfasst von Ryo Kawata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686…. Hauptthemen laut MEDLINE: Parotid Neoplasms, Salivary Gland Neoplasms, Adenoma, Pleomorphic, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: High-grade parotid carcinoma generally has a poor prognosis, and the histological type is mucoepidermoid carcinoma (MEC), salivary duct carcinoma (SDC), carcinoma ex pleomorphic adenoma (CEPA), or adenoid cystic carcinoma (AdCC) in the majority of cases. METHODS: During the 23-year period from September 1999 to December 2022, 250 patients with parotid carcinoma underwent initial treatment and had the histopathological type of their carcinoma. Retrospective study evaluated 111 MEC, SDC, CEPA, or AdCC cases among 134 patients with high-grade parotid carcinoma. We examined pathological and clinical features and prognosis, evaluated factors associated with recurrence, and performed immunohistological examinations. RESULTS: Pathological and clinical features and factors associated with recurrence were different for each histological type. The 10-year disease-free survival rates were as follows: MEC, 34.9%; SDC, 22.6%; CEPA, 47.1%; and AdCC, 56.3%. Human epidermal growth factor receptor type-2 and androgen receptor were positive in 48% and 56% of patients with SDC, respectively, 38% and 25% of those with CEPA. CONCLUSION: Each histological type has its own pathological and clinical features, recurrence types, and tumor activities, suggesting that differentiating between high-grade parotid carcinomas according to histological type will improve diagnosis, and thus prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan. ryo.kawata@ompu.ac.jp.
- Department of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
- Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
- Institutional Research Office, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Zitieren
APA
Kawata, R., Kinoshita, I., Jinnin, T., Higashino, M., Terada, T., Kurisu, Y., Hirose, Y., & Tochizawa, T. (2023). Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-023-02416-9
Vancouver
Kawata R, Kinoshita I, Jinnin T, Higashino M, Terada T, Kurisu Y, et al. Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma. International Journal of Clinical Oncology. 2023. doi:10.1007/s10147-023-02416-9
BibTeX
@article{Kawata2023,
author = {Kawata, Ryo and Kinoshita, Ichita and Jinnin, Tsuyoshi and Higashino, Masaaki and Terada, Tetsuya and Kurisu, Yoshitaka and Hirose, Yoshinobu and Tochizawa, Takeshi},
title = {Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma},
journal = {International Journal of Clinical Oncology},
year = {2023},
doi = {10.1007/s10147-023-02416-9}
}
EUVIMED